Australia's most trusted
source of pharma news
Sunday, 28 April 2024
Posted 26 March 2024 AM
Pfizer has released its fifth Impact Report which covers the pharma's progress on its ESG strategy, and while it is doing well with its environmental goals it has slipped slightly when it comes to employee engagement.
The report provides in-depth coverage of Pfizer's priority ESG issues, which include product innovation, equitable access and pricing, product quality and safety, DEI, climate change, and business ethics.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.